Abstract:In order to solve the influence of uncertain photovoltaic power (PV) on the stable operation of microgrid (MG), demand response (DR) and battery energy storage system (BESS) need to be introduced simultaneously into the operation optimal scheduling of PV-based microgrid (PV-MG). Therefore, it is of great significance for commercial investment decisions of PV-MG to consider the influence of DR on BESS optimal sizing. Under the peak-valley time-of-use (TOU) price, this paper builds cross-time DR models based on price elasticity matrix. Furthermore, through the introduction of DR and BESS into PV-MG scheduling optimization, the MG investment and benefit model is proposed. Considering the constraint condition such as co-ordination of supply and demand, electricity price elasticity and energy loss of storage system, the improved non-dominated sorting genetic algorithm II (NSGA-II) is utilized to solve the multi-objective optimal allocation model of the BESS with the target of maximum PV consumptive rate and annual net profits. The optimization method was applied to a PV-MG in Guangdong. Through the regulation and control effect of demand response and BESS on load distribution, the uncertainties PV power can be suppressed so as to improve the PV system consumptive level, which is of great guiding significance for BESS optimal sizing under this situation.Keywords: time-of-use (TOU) price; multi-period demand response (DR); battery energy storage system (BESS); photovoltaic consumptive rate; investment and benefit model; multi-objective optimization; non-dominated sorting genetic algorithm II (NSGA-II) algorithm
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.